Oric Pharmaceuticals Inc
NASDAQ:ORIC
Balance Sheet
Balance Sheet Decomposition
Oric Pharmaceuticals Inc
Oric Pharmaceuticals Inc
Balance Sheet
Oric Pharmaceuticals Inc
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
43
|
89
|
78
|
226
|
67
|
23
|
59
|
|
| Cash Equivalents |
43
|
89
|
78
|
226
|
67
|
23
|
59
|
|
| Short-Term Investments |
0
|
0
|
215
|
11
|
139
|
185
|
197
|
|
| Other Current Assets |
1
|
1
|
3
|
4
|
4
|
4
|
6
|
|
| Total Current Assets |
44
|
90
|
297
|
241
|
211
|
213
|
262
|
|
| PP&E Net |
3
|
2
|
2
|
2
|
3
|
3
|
11
|
|
| PP&E Gross |
3
|
2
|
2
|
2
|
3
|
3
|
11
|
|
| Accumulated Depreciation |
3
|
4
|
5
|
5
|
6
|
6
|
7
|
|
| Long-Term Investments |
0
|
0
|
0
|
43
|
22
|
27
|
0
|
|
| Other Long-Term Assets |
1
|
2
|
0
|
12
|
12
|
10
|
1
|
|
| Total Assets |
47
N/A
|
94
+101%
|
299
+218%
|
299
0%
|
247
-17%
|
252
+2%
|
274
+9%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
0
|
1
|
2
|
1
|
1
|
2
|
|
| Accrued Liabilities |
2
|
5
|
8
|
13
|
14
|
20
|
23
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
3
|
5
|
9
|
15
|
15
|
20
|
25
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
1
|
0
|
11
|
9
|
7
|
6
|
|
| Total Liabilities |
4
N/A
|
6
+56%
|
9
+51%
|
26
+179%
|
25
-4%
|
28
+13%
|
31
+11%
|
|
| Equity | ||||||||
| Common Stock |
107
|
178
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
66
|
93
|
166
|
245
|
336
|
435
|
562
|
|
| Additional Paid In Capital |
1
|
3
|
456
|
518
|
558
|
659
|
806
|
|
| Total Equity |
43
N/A
|
88
+106%
|
290
+229%
|
273
-6%
|
222
-19%
|
224
+1%
|
243
+8%
|
|
| Total Liabilities & Equity |
47
N/A
|
94
+101%
|
299
+218%
|
299
0%
|
247
-17%
|
252
+2%
|
274
+9%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
28
|
28
|
37
|
39
|
45
|
55
|
71
|
|